Irritable bowel syndrome (IBS) is a common, debilitating, multifactorial, functional gastrointestinal disorder where a definitive aetiology has not been established and no uniformly successful treatment exists. The condition is very prevalent in developed countries with IBS symptoms experienced by 8-22% of the population1. IBS thus poses a significant economic burden on the community as well as the individual.
More: continued here
No Comments so far ↓
There are no comments yet...Kick things off by filling out the form below.